Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, discusses the issue of brain metastasis and the lack of drugs that prevent this type of progression, highlighting osimertinib as a potential drug to reduce these negative outcomes. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.